Aaron Mack
Overview
Explore the profile of Aaron Mack including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
164
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zinabu S, Gasmelseed H, Wheaton N, Girma F, Wong C, Tabraiz S, et al.
Front Psychiatry
. 2025 Jan;
15:1509385.
PMID: 39758443
Introduction: Attention Deficit Hyperactivity Disorder (ADHD), a prevalent neurodevelopmental disorder affecting a significant portion of the population, is commonly managed with stimulant medications. These medications, while effective, have been associated...
2.
Heat Stroke in a Young Athlete With Attention Deficit Hyperactivity Disorder on Stimulant Medication
Qazi O, Mohammed A, Zinabu S, Tabraiz S, Ansari H, Lexima P, et al.
Cureus
. 2024 Sep;
16(8):e68020.
PMID: 39347264
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent patterns of inattention, hyperactivity, and impulsivity that significantly impair daily functioning and quality of life. Although often diagnosed in childhood,...
3.
Gemmell D, Mack A, Wegmann S, Han D, Tuccelli R, Johnson M, et al.
Eng Life Sci
. 2021 Jul;
21(7):502-513.
PMID: 34257631
There is a growing need to provide effective adventitious agent mitigation for high risk upstream cell culture raw materials used for the production of biologics. It is also highly important...
4.
Ratajczak M, Mack A, Bujko K, Domingues A, Pedziwiatr D, Kucia M, et al.
Stem Cell Rev Rep
. 2019 Apr;
15(4):497-505.
PMID: 31020518
Recent evidence indicates that the occurrence of psychiatric disorders in patients is linked to a local "sterile" inflammation of brain or due to a systemic inflammation process that affects the...
5.
Ratajczak M, Bujko K, Mack A, Kucia M, Ratajczak J
Leukemia
. 2019 Mar;
33(4):1058.
PMID: 30842606
The original version of this Article omitted the following from the Acknowledgements.
6.
Udoh K, Parte S, Carter K, Mack A, Kakar S
Stem Cell Rev Rep
. 2019 Mar;
15(4):601-611.
PMID: 30835047
Despite considerable advances made in understanding of lung cancer biology, there has been meek improvement in lung cancer treatment outcome with 4% to 5% increase in 5-year survival rates in...
7.
Ratajczak M, Bujko K, Mack A, Kucia M, Ratajczak J
Leukemia
. 2018 Oct;
32(12):2519-2526.
PMID: 30375490
Tumorigenesis can be considered as pathologically misappropriated tissue regeneration. In this review we will address some unresolved issues that support this concept. First, we will address the issue of the...
8.
McConnell K, Rhudy J, Yokoi K, Gu J, Mack A, Suh J, et al.
J Control Release
. 2014 Sep;
194:113-21.
PMID: 25180449
There is an unmet clinical need to increase lung transplant successes, patient satisfaction and to improve mortality rates. We offer the development of a nanovector-based solution that will reduce the...
9.
van de Ven A, Mack A, Dunner Jr K, Ferrari M, Serda R
Methods Enzymol
. 2012 Mar;
508:1-16.
PMID: 22449918
Logic-embedded vectors (LEVs) have been introduced as a means to overcome sequential, biological barriers that prevent particle-based drug delivery systems from reaching their targets. In this chapter, we address the...
10.
Serda R, Blanco E, Mack A, Stafford S, Amra S, Li Q, et al.
Mol Imaging
. 2011 Feb;
10(1):43-55.
PMID: 21303614
Mass transport of drug delivery vehicles is guided by particle properties, such as size, shape, composition, and surface chemistry, as well as biomolecules and serum proteins that adsorb to the...